These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 3283563

  • 1. A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains.
    Kaslow DC, Quakyi IA, Syin C, Raum MG, Keister DB, Coligan JE, McCutchan TF, Miller LH.
    Nature; 1988 May 05; 333(6168):74-6. PubMed ID: 3283563
    [Abstract] [Full Text] [Related]

  • 2. Malaria vaccine.
    Khurana SK, Talib VH.
    Indian J Pathol Microbiol; 1996 Dec 05; 39(5):433-41. PubMed ID: 9002371
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Synthetic peptides from P. falciparum sexual stage 25-kDa protein induce antibodies that react with the native protein: the role of IL-2 and conformational structure on immunogenicity of Pfs25.
    Quakyi IA, Miller LH, Good MF, Ahlers JD, Isaacs SN, Nunberg JH, Houghten RA, Keister DB, Coligan JE, Moss B.
    Pept Res; 1995 Dec 05; 8(6):335-44. PubMed ID: 8838417
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The development of malaria vaccines: SPf66--what next?
    Tanner M, Alonso PL.
    Schweiz Med Wochenschr; 1996 Jul 09; 126(27-28):1210-5. PubMed ID: 8766632
    [Abstract] [Full Text] [Related]

  • 7. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
    Lalitha PV, Biswas S, Pillai CR, Saxena RK.
    Vaccine; 2008 Aug 18; 26(35):4526-35. PubMed ID: 18590786
    [Abstract] [Full Text] [Related]

  • 8. Clinical and parasitological studies on immunity to Plasmodium falciparum malaria in children.
    Høgh B.
    Scand J Infect Dis Suppl; 1996 Aug 18; 102():1-53. PubMed ID: 9060051
    [Abstract] [Full Text] [Related]

  • 9. Towards a vaccine against malaria.
    McGregor IA.
    Br J Biomed Sci; 1993 Mar 18; 50(1):35-42. PubMed ID: 8032294
    [Abstract] [Full Text] [Related]

  • 10. Advances in vaccine development against the pre-erythrocytic stage of Plasmodium falciparum malaria.
    Walther M.
    Expert Rev Vaccines; 2006 Feb 18; 5(1):81-93. PubMed ID: 16451110
    [Abstract] [Full Text] [Related]

  • 11. Development of malaria vaccines: memorandum from a USAID/WHO meeting.
    Bull World Health Organ; 1983 Feb 18; 61(1):81-92. PubMed ID: 6340848
    [Abstract] [Full Text] [Related]

  • 12. Amino acid dimorphism and parasite immune evasion: cellular immune responses to a promiscuous epitope of Plasmodium falciparum merozoite surface protein 1 displaying dimorphic amino acid polymorphism are highly constrained.
    Daubenberger CA, Nickel B, Ciatto C, Grütter MG, Pöltl-Frank F, Rossi L, Siegler U, Robinson J, Kashala O, Patarroyo ME, Pluschke G.
    Eur J Immunol; 2002 Dec 18; 32(12):3667-77. PubMed ID: 12516559
    [Abstract] [Full Text] [Related]

  • 13. Immunogenicity and in vitro protective efficacy of a polyepitope Plasmodium falciparum candidate vaccine constructed by epitope shuffling.
    Cai Q, Peng G, Bu L, Lin Y, Zhang L, Lustigmen S, Wang H.
    Vaccine; 2007 Jul 09; 25(28):5155-65. PubMed ID: 17548134
    [Abstract] [Full Text] [Related]

  • 14. Pf 155, a candidate for a blood stage vaccine in Plasmodium falciparum malaria.
    Berzins K, Perlmann H, Udomsangpetch R, Wåhlin B, Wahlgren M, Troye-Blomberg M, Carlsson J, Björkman A, Perlmann P.
    Dev Biol Stand; 1985 Jul 09; 62():99-106. PubMed ID: 3914427
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Malaria: recent immunological acquisitions and therapeutic prospects].
    Leri O, Perinelli P, Losi T, Mastropasqua M, Peri C, Tubili S.
    Clin Ter; 1997 Dec 09; 148(12):655-65. PubMed ID: 9528202
    [Abstract] [Full Text] [Related]

  • 17. Pre-erythrocytic malaria vaccine: mechanisms of protective immunity and human vaccine trials.
    Nardin E, Zavala F, Nussenzweig V, Nussenzweig RS.
    Parassitologia; 1999 Sep 09; 41(1-3):397-402. PubMed ID: 10697892
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A novel Plasmodium falciparum sporozoite and liver stage antigen (SALSA) defines major B, T helper, and CTL epitopes.
    Bottius E, BenMohamed L, Brahimi K, Gras H, Lepers JP, Raharimalala L, Aikawa M, Meis J, Slierendregt B, Tartar A, Thomas A, Druilhe P.
    J Immunol; 1996 Apr 15; 156(8):2874-84. PubMed ID: 8609407
    [Abstract] [Full Text] [Related]

  • 20. Induction of protective polyclonal antibodies by immunization with a Plasmodium yoelii circumsporozoite protein multiple antigen peptide vaccine.
    Wang R, Charoenvit Y, Corradin G, Porrozzi R, Hunter RL, Glenn G, Alving CR, Church P, Hoffman SL.
    J Immunol; 1995 Mar 15; 154(6):2784-93. PubMed ID: 7876549
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.